Cannabinoids

Anorexia nervosa (AN) is a psychiatric condition characterized by severe weight loss and secondary problems associated with malnutrition. Here is the latest research on AN.

Cannabinoids

Abstract

References

Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS

Administration of endocannabinoids prevents a referred hyperalgesia associated with inflammation of the urinary bladder

Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study

A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms

Pharmacokinetics and pharmacodynamics of cannabinoids

Initial experiences with medicinal extracts of cannabis for chronic pain: results from 34 'N of 1' studies

Central effects of the cannabinoid receptor agonist WIN55212-2 on respiratory and cardiovascular regulation in anaesthetised rats.

Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial

A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol

Sativex: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain

Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis

The neuropathic pain triad: neurons, immune cells and glia

Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial

Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain

Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.

Interaction of the cannabinoid and opioid systems in the modulation of nociception

Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb

Cannabinoids and the immune system: an overview

The multiple functions of the endocannabinoid system: a focus on the regulation of food intake.

CB2: a cannabinoid receptor with an identity crisis.

The endocannabinoid system as a target for the treatment of neurodegenerative disease.

Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models.

A peripherally restricted cannabinoid receptor agonist produces robust anti-nociceptive effects in rodent models of inflammatory and neuropathic pain.

Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis.

A combined preclinical therapy of cannabinoids and temozolomide against glioma

Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials

Cannabinoid effects on ventilation and breathlessness: a pilot study of efficacy and safety

Intrathecal administration of the cannabinoid 2 receptor agonist JWH015 can attenuate cancer pain and decrease mRNA expression of the 2B subunit of N-methyl-D-aspartic acid

Cannabinoid hyperemesis: a case series of 98 patients.

Intrathecal cannabilactone CB(2)R agonist, AM1710, controls pathological pain and restores basal cytokine levels.

Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain.

Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial

Is the cardiovascular system a therapeutic target for cannabidiol?

An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee

Endocannabinoid signaling and synaptic function.

An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics

A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis

Citations

Conditioned flavor avoidance and conditioned gaping: rat models of conditioned nausea

Prevalence and determinants of cannabinoid prescription for the management of chronic noncancer pain: a postal survey of physicians in the Abitibi-Témiscamingue region of Quebec

Cannabinoid receptor agonism suppresses tremor, cognition disturbances and anxiety-like behaviors in a rat model of essential tremor.

Endogenous cannabinoid receptor agonist anandamide induces peripheral antinociception by activation of ATP-sensitive K+ channels

Cannabinoid type 1 receptors and transient receptor potential vanilloid type 1 channels in fear and anxiety-two sides of one coin?

Tests of unconditioned anxiety - pitfalls and disappointments

Expression pattern of the cannabinoid receptor genes in the frontal cortex of mood disorder patients and mice selectively bred for high and low fear

Modulation of defensive behavior by Transient Receptor Potential Vanilloid Type-1 (TRPV1) channels

Effects of compounds that interfere with the endocannabinoid system on behaviors predictive of anxiolytic and panicolytic activities in the elevated T-maze.

Cannabinoids for epilepsy: What do we know and where do we go?

Optimal condition of cannabis maceration to obtain the high cannabidiol and Δ9-tetrahydrocannabinol content

An Open-Label Pilot Study Testing the Feasibility of Assessing Total Symptom Burden in Trials of Cannabinoid Medications in Palliative Care.

Cannabinoid type 1 receptor antagonism ameliorates harmaline-induced essential tremor in rat

A Review of Cannabis in Chronic Kidney Disease Symptom Management

Cannabidiol is an effective helper compound in combination with bacitracin to kill Gram-positive bacteria.

Cannabinoids and Pain: New Insights From Old Molecules

Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD)

Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD).

From an Alternative Medicine to a New Treatment for Refractory Epilepsies: Can Cannabidiol Follow the Same Path to Treat Neuropsychiatric Disorders?

A Phase 2 Randomised Clinical Trial Assessing the Tolerability of Two Different Ratios of Medicinal Cannabis in Patients With High Grade Gliomas.

Cannabinoids for the treatment of dementia.

Related Concepts

Related Feeds

Anorexia Nervosa

Related Papers

Therapeutic potential of cannabinoid medicines

Systematic review and meta-analysis of cannabis treatment for chronic pain

Cannabinoid and hyperemesis.

Nausea and vomiting: mechanisms and treatment overview

Managing neuropathic pain with Sativex: a review of its pros and cons